[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Briacell Therapeutics Corp WT (BCTXL)

Briacell Therapeutics Corp WT (BCTXL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ -26,312 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7508 +26.19%
on 05/04/26
1.1100 -14.65%
on 05/14/26
-0.0427 (-4.31%)
since 04/22/26
3-Month
0.7508 +26.19%
on 05/04/26
1.2500 -24.21%
on 03/16/26
-0.1526 (-13.87%)
since 02/20/26

Most Recent Stories

More News
BriaCell Presentations Highlight Positive Clinical Data for Bria-IMT™ at ASCO 2026

Final Phase 2 Bria-IMT median overall survival (OS) is 16.6 months (with Phase 3 formulation) Positive Quality of Life (QOL) data from the ongoing Phase 3 study in heavily pre-treated metastatic...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™

BriaCell expands push in women’s health, building on Phase 2 success in advanced metastatic breast cancer Bria-OVA+, BriaCell’s next generation personalized immunotherapy candidate for ovarian...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Completes Manufacturing of Clinical Supplies of Bria-PROS+™ for Prostate Cancer

Bria-PROS+ is BriaCell’s next generation personalized off-the-shelf immunotherapy for prostate cancer Immune stimulating components of Bria-PROS+ enhance anti-tumor responses BriaCell has completed...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Adds Penn Medicine’s Abramson Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

Other recently activated sites include Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Virginia (UVA) Comprehensive Cancer Center, Baptist Health South Florida, and...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Phase 3 Bria-IMT™ Study Enrollment Surpasses 230 Patients

Over 315 patients screened and over 230 patients enrolled in BriaCell’s pivotal Phase 3 Bria-ABC study of Bria-IMT plus immune checkpoint inhibitor in metastatic breast cancer  Enrollment momentum...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Adds NYU Langone Health’s Perlmutter Cancer Center as Clinical Site in Pivotal Phase 3 Breast Cancer Study

PHILADELPHIA and VANCOUVER, British Columbia, May 07, 2026 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXL) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Receives FDA Clearance to Initiate Bria-BRES+™ Clinical Study in Breast Cancer

FDA clearance of Investigational New Drug (IND) application opens path to commence Phase 1/2a clinical study for Bria-BRES+ in metastatic breast cancer Bria-BRES+ is BriaCell’s next generation personalized...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Announces Six Clinical Data Presentations at ASCO 2026

Final randomized Phase 2 Bria-IMT™ survival and quality of life data to be presented Biomarker analyses from the ongoing Phase 3 study evaluating predictors of response PHILADELPHIA and...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Presents Robust Anti-Cancer Activity of Bria-OTS+™ in Preclinical Cancer Models

Bria-OTS+ platform provides early, potent and durable activation of innate and adaptive immunity in in-vitro cancer cell line models Immune cells activated by Bria-OTS+ exhibit serial killing activity...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
BriaCell Presents Positive Phase 3 Quality of Life and Phase 2 Biomarker Data at the 2026 AACR Meeting

Phase 3 clinical data in heavily pretreated metastatic breast cancer patients with prior failed ADC, CPI, and CDK4/6 inhibitor treatments shows quality of life (QOL) largely preserved Identification...

BCT.TO : 4.79 (-5.15%)
BCTXW : 0.0009 (-57.14%)
BCTXZ : 0.0800 (unch)
BCTXL : 0.9474 (-11.04%)
BCTX : 3.49 (-6.18%)
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.